Prognosis of Childhood Atopic Asthma: A 6-year Follow-up Study Çocukluk Çağı Alerjik Astım Prognozu: 6 Yıllık Bir Klinik İzlem Çalışması

Creative Commons License

Erdem S. B., NACAROĞLU H. T., Akçal Ö.

Medical Journal of Bakirkoy, vol.19, no.3, pp.236-241, 2023 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 19 Issue: 3
  • Publication Date: 2023
  • Doi Number: 10.4274/bmj.galenos.2023.2023.1-6
  • Journal Name: Medical Journal of Bakirkoy
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL
  • Page Numbers: pp.236-241
  • Keywords: allergic asthma, asthma remission, natural history, Pediatric asthma, prognostic factors
  • Istanbul Medipol University Affiliated: Yes


Objective: There have been few studies on prognosis and factors influencing the prognosis in children with atopic asthma. We intended to evaluate the prognosis, clinical remission rate, and influencing factors of childhood atopic asthma. Methods: In 72 pediatric patients with atopic asthma who were followed up between 2016 and 2022 with a mean follow-up period of 6.03±2.19 years, demographic characteristics, family history, clinical symptoms, pulmonary function test results, and asthma control test scores were evaluated. Totally controlled patients who had not received any asthma treatment for ≥1 year were considered to be in “clinical remission.” Results: The study group included 72 children with atopic asthma (female/male: 28/44), with a mean age of 13.36±1.98 (8-18) years. 12.5% (n=9) of the patients had uncontrolled asthma, 45.8% (n=33) were partially controlled asthma, 41.7% (n=30) were complete controlled asthma. Clinical remission was seen in 23.6% (n=17) patients with total control. Patients who were symptomatic before the age of three and had a persistent course had a lower clinical remission rate (p=0.05). Conclusion: In our study, the clinical remission rate in atopic asthma in early adulthood was 23.6%. Our results reveal that the clinical remission rate was lower in patients who developed symptoms and had persistent wheezing before the age of three.